Guideline-Recommended Lung Cancer Screening Adherence Is Superior With a Centralized Approach

被引:33
|
作者
Smith, Harrison B. [1 ]
Ward, Ralph [2 ,3 ]
Frazier, Cassie [2 ]
Angotti, Jonathan [1 ]
Tanner, Nichole T. [1 ,3 ]
机构
[1] Med Univ South Carolina, Thorac Oncol Res Grp, Div Pulm & Crit Care, Charleston, SC 29425 USA
[2] Med Univ South Carolina, Dept Publ Hlth, Charleston, SC 29425 USA
[3] Ralph H Johnson Vet Affairs Hosp, Hlth Equ & Rural Outreach Innovat Ctr, Charleston, SC 29401 USA
关键词
adherence; lung cancer; lung cancer screening; thoracic oncology; COMPUTED-TOMOGRAPHY; CHEST PHYSICIANS; IMPLEMENTATION; SELECTION; PROGRAMS; COLLEGE; IMPACT;
D O I
10.1016/j.chest.2021.09.002
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: To recognize fully the benefit of lung cancer screening (LCS), annual adherence must approach the high levels seen in the National Lung Screening Trial. Emerging data suggest that annual adherence is poor and that a centralized approach to screening improves adherence. RESEARCH QUESTIONS: Do differences in adherence exist between a centralized and decentralized approach to LCS within a hybrid program and what are predictors of adherence? STUDY DESIGN AND METHODS: A retrospective evaluation of a single-center hybrid LCS program was conducted to compare outcomes including patient eligibility and adherence between the centralized and decentralized approaches. Patient demographics and outcomes were compared between those screened with a centralized and decentralized approach and between adherent and nonadherent patients using two-sample t tests, chi(2) tests, or analyses of variance, as appropriate. Annual adherence analysis was conducted using data from patients who remained eligible for screening with a baseline Lung CT Screening Reporting and Data System (Lung-RADS) score of 1 or 2. Logistic regression was used to estimate the association between adherence and the primary exposure, adjusting for potential confounders. RESULTS: A cohort of 1,117 patients underwent baseline low-dose CT imaging. Two hundred eleven patients (19%) were ineligible by United States Preventative Services Task Force criteria and most (90%) were screened with the decentralized approach. After exclusions, 765 patients with Lung-RADS score of 1 or 2 remained eligible for annual screening. Overall adherence was 56%; however, adherence in the centralized program was 70%, compared with 41% with the decentralized approach (P <.001). Individuals screened in a decentralized approach were 73% less likely to be adherent (OR, 0.27; 95% CI, 0.19-0.37). A greater proportion of patients with three or more comorbidities were screened outside the centralized program. INTERPRETATION: Those screened using a centralized approach were more likely to meet eligibility criteria for LCS and more likely to return for annual screening than those screened using a decentralized approach.
引用
收藏
页码:818 / 825
页数:8
相关论文
共 50 条
  • [1] Adherence to Guideline-Recommended cancer screening among Utah cancer survivors
    Millar, Morgan M.
    Edwards, Sandra L.
    Herget, Kimberly A.
    Orleans, Brian
    Ofori-Atta, Blessing S.
    Kirchhoff, Anne C.
    Carter, Marjorie E.
    Nagata, Marie
    Sweeney, Carol
    [J]. CANCER MEDICINE, 2023, 12 (03): : 3543 - 3554
  • [2] SURVIVORSHIP CARE PLANNING AND ADHERENCE TO GUIDELINE-RECOMMENDED CANCER SCREENING
    Shay, L. Aubree
    Dioun, Shayda I.
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 : S2437 - S2438
  • [3] Adherence to Guideline-Recommended Cancer Screening in Stroke Survivors: A Nationwide Analysis
    Simonetto, Marialaura
    Rutrick, Stephanie
    LeMoss, Natalie M.
    Lansdale, Kelsey N.
    Tagawa, Scott T.
    Kamel, Hooman
    Parikh, Neal
    Navi, Babak B.
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2022, 31 (03):
  • [4] Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung Cancer
    Elegbede, Anifat A.
    Gibson, Amanda J.
    Fu, Hao
    Dean, Michelle L.
    Ezeife, Doreen A.
    Lau, Harold
    Cheung, Winson Y.
    Bebb, Dafydd G.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (04): : 236 - 242
  • [5] Adherence to guideline-recommended chemotherapy in the treatment of gastric cancer.
    Kish, Jonathan K.
    Seal, Brian S.
    Shermock, Kenneth
    Asche, Carl V.
    Chang, Jane
    Xia, Fang
    Zagadailov, Erin
    Eaddy, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Guideline-Recommended Cancer Screening in Adults with Stroke: A Nationwide Analysis
    Buchman, Stephanie
    Kamel, Hooman
    Navi, Babak
    Parikh, Neal
    [J]. NEUROLOGY, 2020, 94 (15)
  • [7] Expansion of Guideline-Recommended Lung Cancer Screening Eligibility: Implications for Health Equity of Joint Screening and Cessation Interventions
    Salloum, Ramzi G.
    Braithwaite, Dejana
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (01) : 13 - 15
  • [8] ADHERENCE TO GUIDELINE-RECOMMENDED CARE FOR VETERANS WITH CHRONIC KIDNEY DISEASE IN VA
    Chen, Guoqing
    Moran, William
    Egede, Leonard
    Jia, Huanguang
    Yu, Hong-Jen
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 : 219 - 220
  • [9] Drive Time and Receipt of Guideline-Recommended Screening, Diagnosis, and Treatment
    Baldomero, Arianne K.
    Kunisaki, Ken M.
    Wendt, Chris H.
    Bangerter, Ann
    Diem, Susan J.
    Ensrud, Kristine E.
    Nelson, David B.
    Henning-Smith, Carrie
    Bart, Bradley A.
    Hammett, Patrick
    Hagedorn, Hildi J.
    Dudley, R. Adams
    [J]. JAMA NETWORK OPEN, 2022, 5 (11) : E2240290
  • [10] Adherence to guideline-recommended drug therapy in patients with chronic heart failure
    Gredinger, G.
    Wieser, S.
    Trischak, C. M.
    Reitter-Pfoertner, S. E.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2017, 27 : 394 - 394